IL139613A0 - Basb029 polynucleotide(s) and polypetides from neisseria meningitidis - Google Patents

Basb029 polynucleotide(s) and polypetides from neisseria meningitidis

Info

Publication number
IL139613A0
IL139613A0 IL13961399A IL13961399A IL139613A0 IL 139613 A0 IL139613 A0 IL 139613A0 IL 13961399 A IL13961399 A IL 13961399A IL 13961399 A IL13961399 A IL 13961399A IL 139613 A0 IL139613 A0 IL 139613A0
Authority
IL
Israel
Prior art keywords
polypetides
neisseria meningitidis
basb029
basb029 polynucleotide
polypeptides
Prior art date
Application number
IL13961399A
Other languages
English (en)
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10831992&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL139613(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of IL139613A0 publication Critical patent/IL139613A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
IL13961399A 1998-05-13 1999-05-07 Basb029 polynucleotide(s) and polypetides from neisseria meningitidis IL139613A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810276.7A GB9810276D0 (en) 1998-05-13 1998-05-13 Novel compounds
PCT/EP1999/003255 WO1999058683A2 (en) 1998-05-13 1999-05-07 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)

Publications (1)

Publication Number Publication Date
IL139613A0 true IL139613A0 (en) 2002-02-10

Family

ID=10831992

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13961399A IL139613A0 (en) 1998-05-13 1999-05-07 Basb029 polynucleotide(s) and polypetides from neisseria meningitidis
IL139613A IL139613A (en) 1998-05-13 2000-11-10 Compositions of polynucleotide (s) basb029 and polypeptides of neisseria meningitidis, methods of production and their uses

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL139613A IL139613A (en) 1998-05-13 2000-11-10 Compositions of polynucleotide (s) basb029 and polypeptides of neisseria meningitidis, methods of production and their uses

Country Status (23)

Country Link
US (3) US6780419B1 (https=)
EP (2) EP1078063B1 (https=)
JP (2) JP4707832B2 (https=)
KR (4) KR20100019461A (https=)
CN (1) CN1322127C (https=)
AT (1) ATE311457T1 (https=)
AU (1) AU750032B2 (https=)
BR (1) BR9910396A (https=)
CA (1) CA2328403C (https=)
CY (1) CY1105676T1 (https=)
CZ (1) CZ299612B6 (https=)
DE (1) DE69928658T2 (https=)
DK (1) DK1078063T3 (https=)
ES (1) ES2252946T3 (https=)
GB (1) GB9810276D0 (https=)
HU (1) HUP0102479A3 (https=)
IL (2) IL139613A0 (https=)
NO (2) NO326994B1 (https=)
NZ (1) NZ508323A (https=)
PL (1) PL197449B1 (https=)
TR (1) TR200003347T2 (https=)
WO (1) WO1999058683A2 (https=)
ZA (1) ZA200006523B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
AU1979599A (en) * 1998-01-14 1999-08-02 Chiron S.P.A. (neisseria meningitidis) antigens
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
JP4812942B2 (ja) 1999-02-26 2011-11-09 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル ＣＧモチーフを含むオリゴヌクレオチドを用いるＮｅｉｓｓｅｒｉａ抗原殺菌活性の増強
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
RU2281956C2 (ru) 1999-10-29 2006-08-20 Чирон С.Р.Л. Антигенные пептиды neisseria
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
PT2289545T (pt) * 2000-01-17 2016-09-06 Glaxosmithkline Biologicals Sa Vacina de omv suplementada contra meningococos
PL216780B1 (pl) * 2000-01-25 2014-05-30 Univ Queensland Of Santa Lucia Wyizolowane białka zawierające konserwatywne obszary antygenu powierzchniowego NhhA z Neisseria meningitidis, białka fuzyjne, kompozycja farmaceutyczna, przeciwciało monoklonalne lub wiążący antygen fragment przeciwciała monoklonalnego, wyizolowany kwas nukleinowy, konstrukt ekspresyjny, komórka gospodarza, sposób wytwarzania rekombinowanego białka, sposób wykrywania N. meningitidis w próbce biologicznej, sposób diagnozowania zakażenia N. meningitidis oraz sposób wykrywania N. meningitidis w próbce biologicznej uzyskanej od pacjenta oraz zastosowanie wyizolowanego białka, białka fuzyjnego i konstruktu ekspresyjnego
ES2281409T3 (es) 2000-02-28 2007-10-01 Novartis Vaccines And Diagnostics S.R.L. Expresion heterologa de proteinas de neisseria.
BR0211494A (pt) 2001-07-27 2004-08-17 Chiron Srl Adesinas de meningococo nada, app e orf 40
EP1524991A1 (en) 2002-08-02 2005-04-27 GlaxoSmithKline Biologicals S.A. Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
HUE031886T2 (en) 2002-10-11 2017-08-28 Glaxosmithkline Biologicals Sa Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
CN103357002A (zh) 2003-10-02 2013-10-23 诺华疫苗和诊断有限公司 多种脑膜炎球菌血清群的液体疫苗
US7459930B2 (en) * 2006-11-14 2008-12-02 Micron Technology, Inc. Digital calibration circuits, devices and systems including same, and methods of operation
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
GB0916570D0 (en) 2009-09-21 2009-10-28 Royal Holloway & Bedford New C Method
EP2545068B8 (en) 2010-03-11 2018-03-21 GlaxoSmithKline Biologicals S.A. Immunogenic composition or vaccine against gram-negative bacterial, for example neiserial, infection or disease
ES2642184T3 (es) * 2012-01-05 2017-11-15 Deutsches Krebsforschungszentrum Péptidos para su uso en el tratamiento y diagnóstico de cánceres positivos a IDH1 R132H
ES2801054T3 (es) 2016-07-27 2021-01-08 Prysmian Spa Cinta de fibra óptica flexible

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769240A (en) * 1980-09-15 1988-09-06 Bactex, Inc. Pili of neisseria and vaccine compositions containing same
US4702911A (en) * 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
JPH01125328A (ja) 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
US6245337B1 (en) * 1994-08-25 2001-06-12 Washington University Haemophilus adherence and penetration proteins
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
US5646259A (en) * 1995-03-24 1997-07-08 St. Louis University DNA encoding haemophilus adhesion proteins
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
CU22559A1 (es) * 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
AU1979599A (en) * 1998-01-14 1999-08-02 Chiron S.P.A. (neisseria meningitidis) antigens
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
JP2003518363A (ja) * 1999-04-30 2003-06-10 カイロン エセ．ピー．アー． 保存されたナイセリア抗原

Also Published As

Publication number Publication date
HUP0102479A2 (hu) 2001-10-28
ES2252946T3 (es) 2006-05-16
CZ299612B6 (cs) 2008-09-17
EP1621623A2 (en) 2006-02-01
TR200003347T2 (tr) 2001-06-21
ZA200006523B (en) 2001-11-12
KR20080070073A (ko) 2008-07-29
CZ20004202A3 (en) 2001-05-16
BR9910396A (pt) 2001-10-30
HUP0102479A3 (en) 2004-10-28
IL139613A (en) 2014-03-31
NZ508323A (en) 2002-10-25
US6780419B1 (en) 2004-08-24
JP2002514424A (ja) 2002-05-21
NO20090955L (no) 2001-01-11
EP1078063B1 (en) 2005-11-30
PL197449B1 (pl) 2008-03-31
NO326994B1 (no) 2009-03-30
KR100673674B1 (ko) 2007-01-23
DE69928658T2 (de) 2006-06-14
DK1078063T3 (da) 2006-04-03
WO1999058683A2 (en) 1999-11-18
EP1621623A3 (en) 2009-02-18
KR20010043571A (ko) 2001-05-25
JP4707832B2 (ja) 2011-06-22
ATE311457T1 (de) 2005-12-15
CN1309707A (zh) 2001-08-22
CY1105676T1 (el) 2010-12-22
CA2328403C (en) 2013-11-05
DE69928658D1 (de) 2006-01-05
AU750032B2 (en) 2002-07-11
NO20005696L (no) 2001-01-11
WO1999058683A9 (en) 2002-05-02
WO1999058683A3 (en) 2000-04-06
GB9810276D0 (en) 1998-07-15
EP1078063A2 (en) 2001-02-28
NO20005696D0 (no) 2000-11-10
PL345281A1 (en) 2001-12-03
CN1322127C (zh) 2007-06-20
JP2010166921A (ja) 2010-08-05
CA2328403A1 (en) 1999-11-18
KR20100019461A (ko) 2010-02-18
US20090093622A1 (en) 2009-04-09
US20040265332A1 (en) 2004-12-30
AU4142099A (en) 1999-11-29
KR20060076789A (ko) 2006-07-04
HK1036300A1 (en) 2001-12-28
KR100897951B1 (ko) 2009-05-18

Similar Documents

Publication Publication Date Title
IL139613A0 (en) Basb029 polynucleotide(s) and polypetides from neisseria meningitidis
WO1999055873A3 (en) Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
PL345793A1 (en) Neisseria meningitidis
AU5862299A (en) Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses
AU3164600A (en) Novel compounds
WO2000043519A3 (en) Neisseria meningitidis polypeptides
GB9810285D0 (en) Novel compounds
GB9812163D0 (en) Novel compounds
GB9812440D0 (en) Novel compounds
GB0025171D0 (en) Novel compounds
PL345193A1 (en) Basb027 proteins and genes from moraxella catarrhalis
WO2000034482A3 (en) Novel compounds derived from neisseria meningitidis
HK1042515A1 (zh) 來自腦膜炎球菌的basb055多核苷酸和多肽，其使用法
GB9918208D0 (en) Novel compounds
HK1042924A1 (zh) 從淋球性腦膜炎獲得的basb059多肽
GB9918003D0 (en) Novel compounds
GB9918302D0 (en) Novel compounds
GB9918206D0 (en) Novel compounds
GB0025169D0 (en) Novel compounds
GB9918281D0 (en) Novel compounds
GB9914945D0 (en) Novel compounds